The Dow Chemical Company (NYSE:DOW) today announced that Marc van Gerwen has been named Global Business Director for Dow Pharma & Food Solutions. This business has been formerly known as Dow Wolff Cellulosics.
Marc van Gerwen, Global Business Director, Dow Pharma & Food Solutions (Photo: Business Wire)
Dow Pharma & Food Solutions uses natural, plant-based cellulosic technology and companion chemistries to serve the needs of the fast-growing healthcare and medical markets, and to help make everyday foods a little tastier and healthier for consumers. This business also continues to cherish its foundational industrial applications, such as auto-honeycomb and anti-static films as well as conductive pastes for photovoltaic applications.
“This is a business built around helping solve some of the world’s most challenging problems,” said van Gerwen, who is based in Horgen, Switzerland, and assumed the leadership role in late February. “We help bring food to the table that tastes great, but perhaps has a little less fat in it, or gives the consumer that satisfied feeling with smaller amounts of food. We also make high-quality pharmaceutical ingredients designed to help get healing medications to the right part of the body at the right time in the right dosage.
“Our customers count on us to continually develop customized solutions to meet their needs and keep them competitive,” continued van Gerwen. “Understanding customer needs has been at the heart of our business for more than 40 years. We will continue to partner with them to help design even more impactful solutions, such as our new AFFINISOL TM solubilization excipients.”“Marc is the right person for the job,” said Neil Carr, Business President for Functional Materials. “After two years as Marketing and Commercial Director, he knows the business, and many of its customers. He has a demonstrated talent for working closely with them to get good results for all.” Dow Pharma & Food Solutions is one of four business units within Dow’s Functional Materials business group.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts